Experimental drug NU-9 - a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) - improves ...

Addiction research has long endeavored to elucidate the mechanisms that trigger the onset and sustainment of addictive behaviors over time. Why and how can ...

As with its predecessor, the new drug candidate, Jun13296, targets a different viral protein than Paxlovid does and works ...

“If you look at the animal model which people have conducted with Paxlovid, they need to treat the mice with like 150 or even up to 300 milligrams per kilo to achieve similar efficacy,” Wang said.

In attempt to keep R&D costs low, the vivarium business model has emerged as a crucial solution for drug developers.

Drug A killed all the rats ... Indeed, given that problems exist because scientists must extrapolate from animal models to humans, one might think there are good scientific reasons for preferring ...

The development of long-acting drug depots represents a significant advancement in pharmaceutical technology, offering ...